高密度脂蛋白脂组学和CKD中的死亡率
Benjamin Lidgard1, Andrew N Hoofnagle1, Leila R Zelnick1
1University of Washington, Seattle, WA.
Kidney medicine
|September 21, 2023
概括
在慢性病 (CKD) 中,功能障碍的高密度脂蛋白 (HDL) 与死亡率有关. 特定的HDL脂质,如胺和酸胆,增加死亡风险,这表明它们是CKD的新型心血管风险因素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管研究研究心血管研究
- 利皮多米克 (Lipidomics) 是一种消化剂.
背景情况:
- 患有慢性病 (CKD) 的患者表现出功能障碍的高密度脂蛋白 (HDL) 颗粒,缺乏心脏保护作用.
- 高密度胆固醇的脂质组成变化可能是这些功能缺陷的基础,并导致CKD的心血管风险.
研究的目的:
- 为了研究特定的HDL脂质 (胺,胺,胺) 与慢性病患者的全因死亡率之间的关联.
- 在CKD的背景下,在HDL颗粒中识别潜在的新型心血管风险因素.
主要方法:
- 利用了从慢性脏病 (不包括透析/移植) 的成年患者的纵向前队列的数据.
- 通过密度梯度超离心和使用液态染色体协同质谱法 (LC-MS/MS) 量化脂质丰富度来分离高密度液体粒子.
- 采用了多个混因子调整后的考克斯回归模型,并对错误发现率 (FDR) 进行控制.
主要成果:
- 在平均6.12年的随访期间,死亡人数为168人.
- 较高的HDL胺,长链脂肪酸斯芬戈米林和和/单不和酸胆的相对丰度与较高的全因死亡风险 (FDR<5%) 有显著的关联.
- 含有非常长脂肪酸的斯芬哥米林显示出较低死亡风险的趋势.
结论:
- 特定的HDL脂类,包括胺和某些酸胆,与慢性病患者全因死亡风险的增加有关.
- 这些发现表明,高密度胆固醇颗粒的脂质组成变化可能是CKD中新型心血管风险因素.
- 需要进一步的研究来探索这些高密度脂质变化的精确机制和临床影响.
相关概念视频
01:24Chronic Kidney Disease II: Clinical Manifestations
16
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
16
01:25Chronic Kidney Disease I: Introduction
20
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
20
01:28Chronic Kidney Disease III: Interprofessional Care
28
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28
01:18Chronic Kidney Disease IV: Nursing Management
11
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
11
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
179
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
179
01:24Overview of Lipid Metabolism
1.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.7K